Table 1.
Clinical Features of CRC Patients
| Factors | No. of the Patients | Percentage,% |
|---|---|---|
| Sex | ||
| Male | 101 | 54.9% |
| Female | 83 | 45.1% |
| Age (years) | ||
| <60 | 85 | 46.2% |
| ≥60 | 99 | 53.8% |
| Tumor location | ||
| Proximal colon | 47 | 25.5% |
| Distal colon | 62 | 33.7% |
| Rectum | 75 | 40.8% |
| TNM Stages | ||
| Stage I | 21 | 11.4% |
| Stage II | 95 | 51.6% |
| Stage III | 26 | 14.1% |
| Stage IV | 42 | 22.9% |
| HER-2 | ||
| Negative | 68 | 39.8% |
| Positive + | 67 | 39.2% |
| Positive ++ | 36 | 21.0% |
| CD31 | ||
| Negative | 25 | 14.5% |
| positive | 147 | 85.5% |
| D2-40 | ||
| Negative | 25 | 14.5% |
| Positive | 147 | 85.5% |
| Syn | ||
| Negative | 155 | 85.6% |
| Positive | 26 | 14.4% |
| CgA | ||
| Negative | 159 | 87.8% |
| Positive | 22 | 12.2% |
Abbreviations: CRC, colorectal cancer; HER-2, human epidermal growth factor receptor-2; Syn, synaptophysin; CgA, chromogranin A; TNM, Tumor-node-metastasis stage was determined according to the latest guidelines of the Union for International Cancer Control (8th edition).